| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |